For the third quarter, Repligen reported revenue of $155 million, reflecting a 10% year-on-year increase. The organization ...

Rentschler Biopharma began its role as a contract development and manufacturing organization (CDMO) for biopharmaceuticals in 1997. Founded in 1872 as a pharmacy in Laupheim, Germany, the company ...

The contract development and manufacturing organization (CDMO) is adding drug delivery technology to its headquarters, while it has broken ground at its 545,000 square-foot Rockford, Illinois site.

The firm has received a $50 million investment from Texas-based financial aid company Vitrian. This investment includes an option to increase funding up to $65 million. The initial aid will support ...

Family-owned contract development and manufacturing organization (CDMO) Rentschler is constructing a buffer media station at the Laupheim site. Deemed as the “largest single investment” by the firm, ...

First reported by Reuters, this facility will potentially be used as a fill/finish plant to manufacture injection pens for Novo’s star weight loss drugs Wegovy and Ozempic (semaglutide). Confirming ...

This website (the “Site”) is operated by Informa Connect, a trading division of the Informa Group. The parent company of the Informa Group is Informa PLC. Informa Connect (“Informa Connect”, “we” or ...

Biopharmaceutical giant GSK announced a site expansion at its Marietta, Pennsylvania site, where it will build a multipurpose manufacturing facility to produce sterile liquid vaccines and other ...

The deal, first announced in October 2023, sees Thermo gain Olink’s analytical capabilities in diseases at the protein level through its proximity extension assay (PEA) technology. The acquisition, ...

Bionova’s 2,000 L scale facility in Fremont, California marks a full transition to a contract development and manufacturing organization (CDMO) for the bioservices firm. In July 2020, Bionova broke ...

In a Series A financing round led by founding investor Versant Ventures, obesity drug developer SixPeaks has secured $30 million in funding. Beyond this, Anglo-Swedish pharma giant AstraZeneca will ...